Dr Mathias Wipf
BRCCH Consortium Member
University of Applied Sciences and Arts Northwestern Switzerland
Dr Mathias Wipf is working as a guest scientist at the University of Applied Sciences and Arts Northwestern Switzerland (FHNW). He is developing novel in-vitro diagnostics technologies for rapid and point-of-care testing. Dr Wipf is co-founder and CEO of MOMM Diagnostics, a startup company developing rapid tests for preeclampsia, a dangerous pregnancy condition.
Dr Wipf’s background is in nanoscience and physics with a focus on biosensor technologies. He is an innovation driven scientist and entrepreneur with a strong interest in novel sensor concepts for healthcare and biomedical industry, striving to understand fundamental processes and implement technologies to improve the quality of life.